William A. Frazier
Corporate Officer/Principal bei Washington University School of Medicine
Profil
William A.
Frazier is the founder of YourBevCo LLC, founded in 2013, and Arch Oncology, Inc., founded in 2006.
At Arch Oncology, he held the title of Consultant from 2014 to 2015.
Currently, he is a Professor at Washington University School of Medicine.
Dr. Frazier received a doctorate degree from Washington University in St. Louis and an undergraduate degree from The Johns Hopkins University.
Aktive Positionen von William A. Frazier
| Unternehmen | Position | Beginn |
|---|---|---|
| Washington University School of Medicine | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von William A. Frazier
| Unternehmen | Position | Ende |
|---|---|---|
YourBevCo LLC
 YourBevCo LLC Electronic Equipment/InstrumentsElectronic Technology YourBevCo LLC develops beverage devices that remove allergic ingredients. Its flagship product is StiQit that removes all sulfites from cider, champagne, and wine. The company was founded by William A. Frazier on July 11, 2013 and is headquartered in St. Louis, MO. | Gründer | - |
Arch Oncology, Inc.
 Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Gründer | - |
Ausbildung von William A. Frazier
| Washington University in St. Louis | Doctorate Degree |
| The Johns Hopkins University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Commercial Services |
YourBevCo LLC
YourBevCo LLC Electronic Equipment/InstrumentsElectronic Technology YourBevCo LLC develops beverage devices that remove allergic ingredients. Its flagship product is StiQit that removes all sulfites from cider, champagne, and wine. The company was founded by William A. Frazier on July 11, 2013 and is headquartered in St. Louis, MO. | Electronic Technology |